ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾

Annual report pursuant to Section 13 and 15(d)

INVESTMENT IN UNCONSOLIDATED AFFILIATES (Tables)

v3.10.0.1
INVESTMENT IN UNCONSOLIDATED AFFILIATES (Tables)
12 Months Ended
Dec. 31, 2018
INVESTMENT IN UNCONSOLIDATED AFFILIATES Ìý
Schedule of ownership percentage and investment in unconsolidated affiliates

Our ownership percentage and investment in unconsolidated affiliates were as follows (dollars inÌýmillions):

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

DecemberÌý31,Ìý

Ìý

ÌýÌýÌýÌý

2018

ÌýÌýÌýÌý

2017

Equity Method:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Venator Materials PLC (49%)(1)

Ìý

$

219

Ìý

$

Ìýâ€�

BASF ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾ Shanghai Isocyanate InvestmentÌýBV (50%)(2)

Ìý

Ìý

120

Ìý

Ìý

116

Nanjing Jinling ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾ New MaterialÌýCo.,ÌýLtd. (49%)

Ìý

Ìý

163

Ìý

Ìý

124

Jurong Ningwu New Material DevelopmentÌýCo.,ÌýLtd. (30%)

Ìý

Ìý

24

Ìý

Ìý

21

Total equity method investments

Ìý

Ìý

526

Ìý

Ìý

261

Cost Method:

Ìý

Ìý

ÌýÌý

Ìý

Ìý

ÌýÌý

International Diol Company (4%)

Ìý

Ìý

Ìýâ€�

Ìý

Ìý

Ìý5

Total investments

Ìý

$

526

Ìý

$

266

ÌýÌýÌýÌýÌýÌý


(1)

We account for our remaining investment in Venator as an equity method investment using the fair value option. For more information see “Note 4. Discontinued Operations and Business Dispositions—Separation and Deconsolidation of Venator.�

Ìý

(2)

We own 50% of BASF ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾ Shanghai Isocyanate InvestmentÌýBV. BASF ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾ Shanghai Isocyanate InvestmentÌýBV owns a 70% interest in SLIC, thus giving us an indirect 35% interest in SLIC.

Ìý

Summarized financial information of our unconsolidated affiliates

Summarized financial information of our unconsolidated affiliates as of December 31, 2018 and 2017 and for the years ended December 31, 2018, 2017 and 2016 is as follows (dollars in millions):

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

DecemberÌý31,Ìý

Ìý

ÌýÌýÌýÌý

2018

ÌýÌýÌýÌý

2017

Current assets

Ìý

$

1,548

Ìý

$

391

Non-current assets

Ìý

Ìý

2,444

Ìý

Ìý

1,138

Current liabilities

Ìý

Ìý

781

Ìý

Ìý

358

Non-current liabilities

Ìý

Ìý

1,683

Ìý

Ìý

567

Noncontrolling interests

Ìý

Ìý

Ìý8

Ìý

Ìý

Ìýâ€�

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

DecemberÌý31,Ìý

Ìý

ÌýÌýÌýÌý

2018(1)

ÌýÌýÌýÌý

2017

ÌýÌýÌýÌý

2016

Revenues

Ìý

$

2,181

Ìý

$

1,109

Ìý

$

645

Gross profit

Ìý

Ìý

221

Ìý

Ìý

112

Ìý

Ìý

49

Income from continuing operations

Ìý

Ìý

124

Ìý

Ìý

34

Ìý

Ìý

16

Net income

Ìý

Ìý

124

Ìý

Ìý

34

Ìý

Ìý

16


(1)We began accounting for our investment in Venator as an equity method investment on December 3, 2018. Therefore, the summarized financial data only includes information for Venator applicable to the period from December 3, 2018 through December 31, 2018.